Trade

with

Edwards Lifesciences Corp
(NYSE: EW)
AdChoices
116.76
+11.57
+11.00%
After Hours :
116.00
-0.76
-0.65%

Open

113.50

Previous Close

105.19

Volume (Avg)

2.82M (1.03M)

Day's Range

113.22-117.94

52Wk Range

60.62-117.94

Market Cap.

12.38B

Dividend Rate ( Yield )

-

Beta

0.55

Shares Outstanding

106.03M

P/E Ratio (EPS)

16.86 (6.93)

AdChoices
Financials
  • Income Statement
  • Balance Sheet
  • Cash Flow
Operating Income
454.50M
Operating Margin
22.22
Total Equity
-
Retained Earnings
-
Free Cashflow
-
Price/Cashflow
-
Ownership

Institutional Ownership

92.70%

Top 10 Institutions

53.85%

Mutual Fund Ownership

53.63%

Float

73.43%

5% / Insider Ownership

1.12%

Corporate insiders or major stockholders reporting trading activity in the stock.

Top Mutual Fund Owners

Top Institutional Owners

Mutual Fund Name

Institution Name

  • Mutual Fund Name

  • Shares Held

  • % Change

  • % Outstanding

  • VA CollegeAmerica Growth Fund of America

  •  

    6,132,700

  • -24.13

  • 5.78

  • Vanguard Health Care Fund

  •  

    4,920,000

  • -7.59

  • 4.64

  • VA CollegeAmerica AMCAP

  •  

    3,972,900

  • 0.00

  • 3.75

  • Vanguard Mid-Cap Index Fund

  •  

    1,813,966

  • 1.61

  • 1.71

  • Vanguard Total Stock Mkt Idx

  •  

    1,731,867

  • 1.08

  • 1.63

  • VA CollegeAmerica Fundamental Investors

  •  

    1,700,000

  • -48.48

  • 1.60

  • American Funds NVIT Growth-Income Fund

  •  

    1,528,900

  • -1.61

  • 1.44

  • American Funds NVIT Growth

  •  

    1,440,400

  • -52.62

  • 1.36

  • Fidelity® Mid-Cap Stock Fund

  •  

    1,201,400

  • 0.00

  • 1.13

  • UniGlobal

  •  

    1,104,395

  • 8.66

  • 1.04

  • Institution Name

  • Shares Held

  • % Change

  • % Outstanding

  • Capital World Investors

  •  

    12,123,400

  • -3.19%

  • 11.44

  • Capital Research Global Investors

  •  

    10,763,100

  • -18.84%

  • 10.15

  • Vanguard Group, Inc.

  •  

    7,427,673

  • -0.35%

  • 7.01

  • Fidelity Management and Research Company

  •  

    6,682,456

  • -12.39%

  • 6.30

  • Wellington Management Company, LLP

  •  

    4,953,200

  • -6.96%

  • 4.67

  • State Street Corp

  •  

    4,624,367

  • -0.71%

  • 4.36

  • Generation Investment Management LLP

  •  

    4,272,320

  • +78.50%

  • 4.03

  • BlackRock Fund Advisors

  •  

    3,156,566

  • -0.78%

  • 2.98

  • Fairpointe Capital LLC

  •  

    1,616,848

  • -48.83%

  • 1.53

  • Union Investment Privatfonds GmbH

  •  

    1,457,459

  • +13.25%

  • 1.38

Company Profile

Sector

Healthcare

Industry

Medical Devices

Type

Aggressive Growth

Style

Mid Growth

Edwards Lifesciences Corp was incorporated in Delaware on September 10, 1999. The Company is the manufacturer of heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. It is also a g...morelobal leader in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. It conducts operations worldwide and are managed in the following geographical regions: United States, Europe, Japan and Rest of World. The products and technologies provided by the Company to treat advanced cardiovascular disease or critically ill patients are categorized into the following main areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. The Company's Surgical Heart Valve Therapy portfolio includes tissue he...moreart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Company's Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. In the Critical Care portfolio, Edwards Lifesciences' products include pulmonary artery catheters, disposable pressure transducers and advanced monitoring systems. The portfolio also includes a line of balloon catheter-based vascular products, surgical clips and inserts. The Company competes with many companies, including divisions of companies much larger than it and smaller companies that compete in specific product lines or certain geographies. The Company’s Surgical Heart Valve Therapy and Transcatheter Heart Valve products are manufactured in California and Utah in the United States, Switzerland, and Singapore. Critical Care products are manufactured primarily in its facilities located in Puerto Rico and the Dominican Republic. The Company’s products and technologies are subject to regulation by numerous domestic and foreign government agencies, including the FDA, and various laws and regulations governing the development, testing, manufacturing, labeling, marketing and distribution of its products and technologies.lessless

Key People

Michael A. Mussallem

CEO/Chairman of the Board/Director

Scott B. Ullem

CFO/Vice President

Aimee S. Weisner

General Counsel/Vice President

Donald E. Bobo,Jr

Vice President, Divisional

Larry L. Wood

Vice President, Divisional

Incorporated

1999

Employees

-

Send Feedback

We appreciate your input!

  • I'm having trouble signing into my Microsoft account

  • I’m having problems with the services stripe (Mail, Facebook, etc.)

  • There is an issue with my weather information

  • I see an error in the content

  • Other

Please give an overall site rating: